Sio Capital Management, LLC - 30 Jun 2025 SCHEDULE 13G Report for Aligos Therapeutics, Inc. Common Stock, par value, $0.0001 per share (ALGS)

Filing Manager: Sio Capital Management, LLC
Reporting Manager: Sio Capital Management, LLC
Security: Aligos Therapeutics, Inc. Common Stock, par value, $0.0001 per share
Symbol: ALGS
Shares outstanding: 6,483,370 shares
Disclosed Ownership: 355,937 shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Filing time: 13 Aug 2025, 14:00:06 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Sio Capital Management, LLC	5.5%	355,937	0	355,937	/s/ Jin W. Lee	Chief Compliance Officer